企業プロフィール
Citius Pharma 株価・ニュース・カタリスト
- ティッカー:
- CTXR
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
0.56 USD (-25.62%)
終値
最終更新: 2026年8月17日
16.6M USD
時価総額
株価変動の要因
As of Aug 17, 2026, CTXR closed down 25.6% at $0.5620. No new same-company headline was identified in the current news window.
企業概要
事業概要
Citius Pharma is a specialty pharmaceutical company focused on anti-infective, oncology-supportive, and hospital-related products. Its story is centered on commercializing a small number of highly specific healthcare assets.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, Citius sits in specialty biopharma.
ビジネスモデルの特徴
The business depends on product development, regulatory steps, and the ability to create commercial value from focused assets.
バイオ業界での位置付け
Citius is a small-cap specialty-pharma name whose stock is driven by launch and regulatory milestones.
今後のカタリスト
- Citius’s catalysts are LYMPHIR and Mino-Lok-related updates, with the market watching whether the company can finally turn its infection-control story into something more durable. The next event that matters is the one that confirms the company still has a viable commercial path.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。